Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is to determine the efficacy and safety of the association clotrimazole 200mg and metronidazole 0,75%(Clopistatin 5DT®) and whether it is superior when compared with metronidazole 100mg/g (gynecologic Flagyl®) and clotrimazole 20mg/g (Gino-Canesten® 3) in the syndromic treatment of vaginal discharge from different etiologies.


Clinical Trial Description

n/a


Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms


NCT number NCT02713139
Study type Interventional
Source Ache Laboratorios Farmaceuticos S.A.
Contact
Status Withdrawn
Phase Phase 3
Start date September 2013

See also
  Status Clinical Trial Phase
Completed NCT02641717 - Validity of Patient-Collected Wet Mounts N/A
Terminated NCT03943823 - Postmenopausal Pessary Users: Estrogen Versus Trimosan Phase 4
Completed NCT04472377 - Agreement of hrHPV Type Between Self-collected Sample From Vaginal Fornix and Physician Collected Sample From the Cervical Surface N/A
Completed NCT02111629 - Safety and Clinical and Microbiological Efficacy of the Combination of Fluconazole and Secnidazole for the Treatment of Symptomatic Vaginal Discharge Phase 3
Completed NCT05201313 - Efficacy and Safety of the Application of Local Anaesthetic in Spray to Repair of 1st- 2nd Perineal Lacerations Phase 3
Recruiting NCT04885556 - Evaluation of a Novel Female Hygiene Device for Postcoital Discomfort N/A
Recruiting NCT05977491 - Point-of-care Tests for Vaginal Discharge in Nepal N/A
Completed NCT01347632 - Study of How Bacterial Vaginosis and Its Treatment Affects Cervical and Vaginal Tissue N/A
Recruiting NCT02898818 - Vaginal and Oral Microbiome Crosstalk